ArticleFrontiers in medicine2026
Medication adherence rates in patients with ocular inflammatory disease.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To evaluate medication adherence patterns in patients with ocular inflammatory disease. Methods: This cross-sectional study involved patients with ocular inflammatory disease who completed a questionnaire assessing demographics, disease characteristics, understanding of condition and medication regimen, self-reported adherence and methods utilized to improve adherence. Accuracy of self-reported responses were validated against electronic hospital records. Univariate and multivariate analyses were performed to identify factors associated with adherence and understanding. Results: Of the 75 patients with ocular inflammatory disease, 14 (18.7%) were evaluated to be highly adherent to their prescribed medications, despite 33 (44%) reporting no perceived barriers to adherence. 38 (50.6%) were unable to recall the purpose of their medications, despite 59 (78.6%) reporting that the purpose of their medications was clearly explained to them. The ability to accurately recall their ocular inflammatory diagnosis ( Conclusion: Medication adherence in ocular inflammatory disease is suboptimal. Our results indicate a discordance between explained and recalled medication and condition information, impacting adherence negatively. Targeted educational interventions may be required to enhance patients' understanding and retention of key information regarding their ocular inflammatory disease and medication regimen to improve adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.